ELMMB logo
Facebook logo Twitter logo
Menu

Drug Alerts and Withdrawals

Drug Alerts and Withdrawals
 For more information about the MHRA click here 
 For MHRA Drug Safety Updates click here

When the MHRA, or occasionally another regulatory body in another country, such as the FDA, release advice, it is sometime necessary to produce additional local guidance.  This aims to be both clear and concise advice to healthcare professionals on the local action required to implement or respond to alerts issued by the MHRA or other bodies.  These memorandums are available below for reference, once they have been circulated to the relevant professionals in primary and secondary care:

MHRA News Stories.

 11th October 2023       MHRA Press Release: SteriFeed colostrum collector not to be used to directly feed babies due to choking risk, 
                                         MHRA advises.
 15th September 2023 MHRA News:  MHRA approves Moderna’s adapted COVID-19 vaccine (Spikevax) that targets Omicron XBB.1.5

 

MHRA Company-led Drug alerts

click here to access the most recent alerts

Clexane 10000IU per 1ml syringes Star Pharm_class 4 meds defect EL_22_A08.pdf

Clexane 10000IU per 1ml syringes Star Pharm_class 4 meds defect EL_22_A08.pdf
Summary: Drugsrus Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in specific batches of Clexane 10,000IU (100mg)/1 ml Syringes contains a typographical error in the leaflet. The strength of the product listed in the leaflet header states “100,000 IU (100mg) / 1ml” instead of “10,000 IU (100mg)/1ml”. The remainder of the packaging, including the outer packaging and information on the syringe itself details the correct strength of 10,000 IU (100mg)/1ml.
File Size: 135KB
Type: Files / Images
Created: 09 March 2023
Last Modified: 09 March 2023